Tumor-associated macrophages stimulate the proliferation of murine tumor cells surviving treatment with the oncolytic cyclophosphamide analogue ASTA Z-7557:In vivo implications

1984 ◽  
Vol 34 (6) ◽  
pp. 883-890 ◽  
Author(s):  
Robert Evans ◽  
Theodore Duffy ◽  
Richard T. Cullen
1996 ◽  
Vol 42 (2) ◽  
pp. 175-184 ◽  
Author(s):  
K. Itoi ◽  
C-Y. Tabata ◽  
O. Ike ◽  
Y. Shimizu ◽  
M. Kuwabara ◽  
...  

1980 ◽  
Vol 98 (1) ◽  
pp. 51-58 ◽  
Author(s):  
P. Janik ◽  
W. Roszkowski ◽  
H. L. Ko ◽  
S. Szmigielski ◽  
G. Pulverer ◽  
...  

Oncology ◽  
1984 ◽  
Vol 41 (1) ◽  
pp. 43-48 ◽  
Author(s):  
Kouji Okamoto ◽  
Yoshifumi Tomita ◽  
Hiroo Yonezawa ◽  
Tomio Hirohata ◽  
Ryohei Ogura ◽  
...  

1995 ◽  
Vol 182 (5) ◽  
pp. 1415-1421 ◽  
Author(s):  
T C Wu ◽  
A Y Huang ◽  
E M Jaffee ◽  
H I Levitsky ◽  
D M Pardoll

Introduction of the B7-1 gene into murine tumor cells can result in rejection of the B7-1 transductants and, in some cases, systemic immunity to subsequent challenge with the nontransduced tumor cells. These effects have been largely attributed to the function of B7-1 as a costimulator in directly activating tumor specific, major histocompatibility class I-restricted CD8+ T cells. We examined the role of B7-1 expression in the direct rejection as well as in the induction of systemic immunity to a nonimmunogenic murine tumor. B-16 melanoma cells with high levels of B7-1 expression did not grow in C57BL/6 recipient mice, while wild-type B-16 cells and cells with low B7-1 expression grew progressively within 21 d. In mixing experiments with B7-1hi and wild-type B-16 cells, tumors grew out in vivo even when a minority of cells were B7-1-. Furthermore, the occasional tumors that grew out after injection of 100% B-16 B7-1hi cells showed markedly decreased B7-1 expression. In vivo antibody depletions showed that NK1.1 and CD8+ T cells, but not CD4+ T cells, were essential for the in vivo rejection of tumors. Animals that rejected B-16 B7-1hi tumors did not develop enhanced systemic immunity against challenge with wild-type B-16 cells. These results suggest that a major role of B7-1 expression by tumors is to mediate direct recognition and killing by natural killer cells. With an intrinsically nonimmunogenic tumor, this direct killing does not lead to enhanced systemic immunity.


Author(s):  
Alexandra Treister ◽  
Orit Sagi-Assif ◽  
Michal Meer ◽  
Nechama I. Smorodinsky ◽  
Romema Anavi ◽  
...  

1989 ◽  
Vol 68 (2) ◽  
pp. 186-191 ◽  
Author(s):  
Angela Dieckmann-Schuppert ◽  
Andreas Ruppel ◽  
Reinhard Burger ◽  
Werner Frank

Sign in / Sign up

Export Citation Format

Share Document